|
unsaturated fatty acid
|
CHEBI_27208 |
[Any fatty acid containing at least one C=C or C#C bond.] |
|
Proboscis
|
HP_0012806 |
[A fleshy, tube-like structure usually located in the midline of the face or just to one side of the midline.] |
|
Iris transillumination defect
|
HP_0012805 |
[Transmission of light through the iris as visualized upon slit lamp examination or infrared iris transillumination videography. The light passes through defects in the pigmentation of the iris.] |
|
Corneal ulceration
|
HP_0012804 |
[Disruption of the epithelial layer of the cornea with involvement of the underlying stroma.] |
|
Hypoparathyroidism
|
HP_0000829 |
[A condition caused by a deficiency of parathyroid hormone characterized by hypocalcemia and hyperphosphatemia.] |
|
Abnormality of the parathyroid physiology
|
HP_0011767 |
[A functional abnormality of the parathyroid gland.] |
|
Hyperinsulinemic hypoglycemia
|
HP_0000825 |
[An increased concentration of insulin combined with a decreased concentration of glucose in the blood.] |
|
Hyperinsulinemia
|
HP_0000842 |
[An increased concentration of insulin in the blood.] |
|
glutathione
|
CHEBI_16856 |
[A tripeptide compound consisting of glutamic acid attached via its side chain to the N-terminus of cysteinylglycine.] |
|
tripeptide
|
CHEBI_47923 |
[Any oligopeptide that consists of three amino-acid residues connected by peptide linkages.] |
|
L-cysteine derivative
|
CHEBI_83824 |
[A proteinogenic amino acid derivative resulting from the formal reaction of L-cysteine at the amino group, carboxy group, or thiol group, or from the replacement of any hydrogen of L-cysteine by a heteroatom.] |
|
thiol
|
CHEBI_29256 |
[An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.] |
|
Abnormality of the parathyroid gland
|
HP_0000828 |
[An abnormality of the parathyroid gland.] |
|
Hypothyroidism
|
HP_0000821 |
[Deficiency of thyroid hormone.] |
|
Growth delay
|
HP_0001510 |
[A deficiency or slowing down of growth pre- and postnatally.] |
|
Decreased response to growth hormone stimulation test
|
HP_0000824 |
[Insufficient responses to growth hormone (GH) provocation tests. GH deficiency is defined as a serum peak GH concentration less than 10 ng/mL on provocation with a combination of at least two separate stimulation tests.] |
|
Abnormal response to endocrine stimulation test
|
HP_0031073 |
[An anomalous response to a test that is designed to probe the function of the endocrine system.] |
|
Anterior hypopituitarism
|
HP_0000830 |
[A condition of reduced function of the anterior pituitary gland characterized by decreased secretion of one or more of the pituitary hormones growth hormone, thyroid-stimulating hormone, adrenocorticotropic hormone, prolactin, luteinizing hormone, and follicle-stimulating hormone.] |
|
Hypopituitarism
|
HP_0040075 |
|
|
Insulin-resistant diabetes mellitus
|
HP_0000831 |
[A type of diabetes mellitus related not to lack of insulin but rather to lack of response to insulin on the part of the target tissues of insulin such as muscle, fat, and liver cells. This type of diabetes is typically associated with increases both in blood glucose concentrations as well as in fasting and postprandial serum insulin levels.] |